These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22493462)

  • 21. Immune efficacy of first and repeat trivalent influenza vaccine in healthy subjects and hemodialysis patients.
    Mastalerz-Migas A; Bujnowska-Fedak M; Brydak LB
    Adv Exp Med Biol; 2015; 836():47-54. PubMed ID: 25248348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
    Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety.
    Remschmidt C; Wichmann O; Harder T
    BMC Med; 2014 Dec; 12():244. PubMed ID: 25523432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017.
    Ng Y; Nandar K; Chua LAV; Mak TM; Foo K; Muhammad IR; Low CKK; Ma S; Ooi SP; Lin RTP; James L; Lee VJM
    Vaccine; 2019 Jun; 37(29):3925-3931. PubMed ID: 31160102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15.
    Ferdinands JM; Fry AM; Reynolds S; Petrie J; Flannery B; Jackson ML; Belongia EA
    Clin Infect Dis; 2017 Mar; 64(5):544-550. PubMed ID: 28039340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.
    Flannery B; Chung JR; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Foust A; Sessions W; Berman L; Barnes JR; Spencer S; Fry AM
    MMWR Morb Mortal Wkly Rep; 2018 Feb; 67(6):180-185. PubMed ID: 29447141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effectiveness of trivalent inactivated influenza vaccine and live, attenuated influenza vaccine in preventing influenza-like illness among US military service members, 2006-2009.
    Phillips CJ; Woolpert T; Sevick C; Faix D; Blair PJ; Crum-Cianflone NF
    Clin Infect Dis; 2013 Jan; 56(1):11-9. PubMed ID: 23183869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Chu S; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2019 Sep; 220(8):1255-1264. PubMed ID: 30561688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15.
    Qin Y; Zhang Y; Wu P; Feng S; Zheng J; Yang P; Pan Y; Wang Q; Feng L; Pang X; Puig-Barberà J; Yu H; Cowling BJ
    Vaccine; 2016 Apr; 34(20):2329-33. PubMed ID: 27026147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.
    Ridenhour BJ; Campitelli MA; Kwong JC; Rosella LC; Armstrong BG; Mangtani P; Calzavara AJ; Shay DK
    PLoS One; 2013; 8(10):e76318. PubMed ID: 24146855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons.
    Thompson MG; Li DK; Shifflett P; Sokolow LZ; Ferber JR; Kurosky S; Bozeman S; Reynolds SB; Odouli R; Henninger ML; Kauffman TL; Avalos LA; Ball S; Williams JL; Irving SA; Shay DK; Naleway AL;
    Clin Infect Dis; 2014 Feb; 58(4):449-57. PubMed ID: 24280090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of influenza vaccine in the community-dwelling elderly.
    Nichol KL; Nordin JD; Nelson DB; Mullooly JP; Hak E
    N Engl J Med; 2007 Oct; 357(14):1373-81. PubMed ID: 17914038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15.
    Leval A; Hergens MP; Persson K; Örtqvist Å
    Euro Surveill; 2016 Oct; 21(43):. PubMed ID: 27813473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
    Puleston RL; Bugg G; Hoschler K; Konje J; Thornton J; Stephenson I; Myles P; Enstone J; Augustine G; Davis Y; Zambon M; Nicholson KG; Nguyen-Van-Tam JS
    Health Technol Assess; 2010 Dec; 14(55):1-82. PubMed ID: 21208547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of trivalent inactivated influenza vaccine among community-dwelling older adults in Thailand: A two-year prospective cohort study.
    Prasert K; Patumanond J; Praphasiri P; Siriluk S; Ditsungnoen D; Chittaganpich M; Dawood FS; Mott JA; Lindblade KA
    Vaccine; 2019 Feb; 37(6):783-791. PubMed ID: 30616956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20.
    Baum U; Kulathinal S; Auranen K
    Euro Surveill; 2021 Sep; 26(36):. PubMed ID: 34505568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment.
    Regan AK; Fielding JE; Chilver MB; Carville KS; Minney-Smith CA; Grant KA; Thomson C; Hahesy T; Deng YM; Stocks N; Sullivan SG
    Vaccine; 2019 May; 37(19):2634-2641. PubMed ID: 30952499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.